SlideShare a Scribd company logo
Popeye Retinopathy
Dr Giulio Bamonte- Dr.ssa Rossella Melchionda
13-5-2019 Paziente Ispanico di 26 anni maschio, si presenta in PS con
calo del visus da un giorno in OS, prima intermittente con flash e poi
dalla mattina permanente.
L’OD e’ normale.
Visus OD 10/10 nat
Visus OS 1/50 nmcl,
tono 11mmHg OO.
Anamnesi generale, oculare e familiare negativa per patologie degne di
nota.
Va tutti i giorni in Palestra.
DD: Valsalva Retinopathy, viene inviato al Chirurgo VR. Si esegue
Retinografia e OCT.
13-5-2019
Valsalva Retinopathy
• Particular form of retinopathy, pre-retinal and hemorrhagic in nature,
secondary to a sudden increase in intrathoracic pressure.
• It was used to describe retinal hemorrhages in association with heavy
lifting, coughing, straining at stool, or vomiting.
• Valsalva retinopathy classically manifests as preretinal hemorrhage
secondary to rupturing of superficial retinal vessels caused by physical
exertion.
• The mechanism of a Valsalva maneuver is characterized by a sudden rise in
intrathoracic or intraabdominal pressure against a closed glottis, which
leads to a rapid rise of intravenous pressure within the eye, causing
retinal capillaries to spontaneously rupture.
DD of Valsalva
Retinopathy
Anemic Retinopathy
Diabetic Retinopathy
Hemorrhagic Posterior Vitreous Detachment
Hypertensive Retinopathy
Ocular Parasitic Infection
Purtscher Retinopathy and Purtscher-like
Retinopathy
Retinal Macroaneurysm
Retinal Vein Occlusion (RVO)
Sickle Cell Retinopathy
Terson Syndrome
14-5-2019 Alla visita VR oltre quanto visibile in Retinografia si apprezza
nei quadranti superiori un aspetto vascolare ristretto, con vasi a
salsicciotto.
Il segmento anteriore e’ in quiete. Si invia per FAG, visita con esperto
Uveiti e consulto internistico.
Si esegue FAG.
14-5-2019
15-5-2019 Il paziente avverte un leggero discomfort su OS. Situazione
oculare invariata. Si consiglia solo riposo. L’esperto di uveiti pone la
seguente DD: problema vascolare tipo papilloflebite (Ipertensione,
dislipidemia, coagulopatie), problema infiammatorio (meno probabile,
Sarcoidosi, Hiv, TBC, Sifilide, MS, Bechet, Chron, PAN).
Papillophlebitis
• Papillophlebitis is a condition in which the clinical features of central retinal
vein occlusion (CRVO) are present but there is no history of vascular
disease.
• Papillophlebitis is characterized by painless unilateral disc edema and
hyperemia, retinal venous engorgement, and a variable extent of
intraretinal hemorrhage and macular edema in otherwise healthy adults
younger than 50 years.
• Papillophlebitis is often associated with systemic vascular disease (eg,
arterial hypertension, diabetes) or hematologic disorders.
• Corticosteroids, both systemic and periocular, are the mainstay of
treatment and are often coupled with anticoagulants such as heparin
and/or aspirin to reduce inflammation and treat any underlying
coagulopathies
Papillophlebitis
Q: When and for whom is thrombophilia testing appropriate?
A: Because papillophlebitis can be the first sign of an underlying
connective tissue disorder (eg, lupus, rheumatoid arthritis), young
women may benefit from a hematologic rheumatologic referral.
Screening for hypercoagulable status may include the following:
• Antiphospholipid antibodies and hyperhomocysteinemia;
• Factor V Leiden and prothrombin G20210A mutations; and
• Additional thrombotic risk factors such as pregnancy.
20-5-2019 Al controllo si apprezzano 1+ cell in CA + depositi edoteliali. Il
vitreo appare limpido. Per il resto invariato.
Si instaura tp locale con Prednisolone collirio 6 al di e unguento prima di
dormire + cyclolux 2 al di.
22-5-2019 1+ cell in CA e depositi endoteliali, cellule in CV (globuli rossi,
spill over?).
Visus OS 2/10 con miglioramento dell’emorragia, che sta liberando il
centro della macula.
I vasi sembrano obliterati sia nasalmente che temporalmente, possibile
vasculite. Le arteriole sono ristrette, sembra aspetto a vasculite venosa.
Visita Internistica: Pz Ecuadoregno. Ultimo viaggio un anno prima. Un
anno prima negativo STD. No contatti TB. Anamnesi prossima negativa.
Anamnesi remota positiva per polmonite a 5 mesi di vita. Nega
assuzione di droghe e alcol (sociale). In un relazione fissa da 6 anni.
Esame fisico e di Laboratorio negativo
Visita internistica 20-5-2019
• Controles: RR 130/93, pols 62/min, Lengte: 162cm, gewicht 72kg (met kleding), BMI 27, H/H: geen lymfadenopathie in de
hals of supraclaviculair. Inspectie keel: geen roodheid, geen zwelling. Cor: S1S2, geen souffle Pulm: beiderzijds VAG zonder
bijgeluiden Abd: soepel, NP, WT, geen drukpijn, geen hepatosplemomegalie Extr: soepele kuiten, geen oedemen Geen
huidafwijkingen, behoudens enkele puistjes op de thorax. Geen afwijkingen aan de nagels.
• Laboratorium 16-06 Ureum 4.1, Kreatinine 82, natrium 142, kalium 4.3, ASAT 26, ALAT 30, LD 161, Bilirubine 9, Alk Fos 81,
Hb 10.0, Leukocyten 7.5, Trombocyten 238, Bezinking 2, CRP <1, Ferritine 131, Vit B12 323, Foliumzuur 11.4
• Conclusie: Retinabloeding links met atypisch beeld bij oogheelkundig onderzoek mogelijk passend bij vasculitis dan wel
veneus occlusie beeld DD - Cardiovasculair (HT, dyslipidemie) - Trombus bij hypercoagulabiliteit (factor V Leiden,
homocysteinemie, antifosfolipiden) - Papillophlebitis t.g.v. inflammatie, echter inflammatieparamters laag (vasculitis
ihkv M. Behcet, Crohn, PAN, sarcoïdose, MS, SLE; infectieus ihkv HIV, CMV, Syfilis, toxoplasmose, TB (Eales disease),
virale hepatitis)
• Beleid: Aanvullend lab: lipidenspectrum, HbA1c, nuchter glucose - USED + totaal eiwit, kreatinine, microalbumine -
Controle 1-2 weken met Dynamap vooraf - Te bespreken: ANA/ANCA, factor V Leiden, homocysteine, antifosfolipiden -
PM: TB, HIV, CMV, toxoplasmose screening
• 22-5-2019 Lijkt een veneus probleem (DD trombotisch danwel inflammatoir), overige is er secundair aan. - Vandaag nog
prikken: antifosfolipidensyndroom (Lupus anticoagulans, anti cardiolipine, beta-2 glycoproteine), complement (C1q, C3,
C4), ANA screening, HIV, Lues serologie - X-thorax bij nog sarcoïdose in de DD - Controle a.s. maandag reeds gepland -->
dan 24-uurs bloeddrukmeting regelen ter uitsluiting nachtelijke hypertensie - Geen antistolling, geen reden voor prikken
stollingsfactoren
Visita internistica 27-5-2019
Dynamap: RR 115/65 mmHg Lab: Ur 4.1 Kreat 88
Leverchemie nl Hb 10 MCV 87 T 238 L 7.5 BSE 2 INR 1.0 APTT 26 Hba1c 35
Lipiden: Cholesterol 4.6 TG 1.0 LDL 3.6
APS: beta 2 glycoproteine, cardiolipine IgM/IgG negatief. Lupus anticoagulans volgt
Complement: volgt ANA screening: < 0.5 Sarcoidose: ACE, S-IL2R volgt
Used: leuko's, eiwit, ery's negatief. MMB
HIV: negatief T.Pallidum negatief. TB quantiferon negatief.
X-Thorax: Normale thorax. Geen aanwijzing voor sarcoïdose.
Conclusie: - Cardiovasculair DD Hypertensie. Geen dislypidemie (LDL 3.6) > 24u BD meting volgt
DD Trombus bij hypercoagulabiliteit ikv factor V Leiden, homocysteinemie, antifosfolipiden >cardiolipine, betaglycoproteine neg, lupus anticoagulans volgt
- Retinale vasculitis, echter BSE laag (2) DD auto-immuun mgk ihkv M. Behcet, Crohn, PAN, sarcoïdose, MS, SLE, GCA
> ANA negatief > s-IL2R/ACE volgt > complement volgt
DD infectieus, mgk ihkv CMV, Toxoplasmose, HSV/VZV, CMV). > HIV/Lues/ TB serologie negatief
Beleid - 24u bloeddrukmeting ter uitsluiting nachtelijke hypertensie PM volgende keer dieetadvies (LDL 3.6)
PM nog FVL en homocysteine bepalen? --> iom Soonwala, niet nodig, gezien geen behandelconsequenties (geen zin om antistolling te starten)
27-5-2019 Visita Oculistica con FAG: nasalmente si apprezza ischemia,
ma l’area e’ ancora coperta dal sangue. Aspetto a Frosted Branch
Arteritis (che pero’prende sia vene che arterie)? In CA le cellule sono
diminuite. Tp steroidea locale a scalare.
22-5-2019
27-5-2019
Frosted Branch Angiitis
• Usually bilateral
• Specific Syndrome (primary form): rare, children or young adults
• Common immune pathway in responde to multiple infective agents:
CMV retinitis.
• Oher conditions suchs glomerulonefritis and CRVO
Frosted Branch Angiitis
Visual Acuity usually very poor
Florid translucent retinal perivascular
sheating of both arteriooles and venules
Anterior uveitis, vitritis and retinal oedema
Papillitis, hard exudates, retinal hemorrhages
and venous occulsion
TP is with steroid.
28-5-2019 Consulto con collega dell’Universita’ di Leiden: sospetta
Valsalva in un caso di Retinopatia Purtscher che tuttavia da’ una
problematica di solito a livello del polo posteriore, qui il problema e’
nasale (papillo flebite/crvo).
Purtscher Retinopathy
• Purtscher retinopathy is a hemorrhagic and vasoocclusive
vasculopathy, which, was first described as a syndrome of sudden
blindness associated with severe head trauma. These patients had
findings of multiple white retinal patches and retinal hemorrhages
that were associated with severe vision loss.
• Purtscher (and Purtscher like) retinopathy has been associated with
traumatic injury, primarily blunt thoracic trauma and head trauma,
and numerous nontraumatic diseases.
DD of Purtscher
Retinopathy
• Acute Pancreatitis;
• fat embolization;
• amniotic fluid embolization;
• preeclampsia;
• hemolysis, elevated liver enzymes, and
low platelets (HELLP) syndrome;
• and vasculitic diseases, such as lupus.
Patients with known vasculitic disease
(eg, systemic lupus erythematosus,
scleroderma, dermatomyositis) are at risk
for developing a Purtscher-like
retinopathy with microvascular
occlusion
Pathophysiology of Purtsher Retinopathy
• These lesions are known as Purtscher flecken (larger infarcts of the
retinal capillary bed) and cotton-wool spots (small retinal
microinfarcts at the level of the nerve fiber layer).
• Fluorescein leakage in Purtscher retinopathy suggests that an acute
endothelial cell injury is caused by trauma, possibly predisposing
the retinal vessels to occlusion
Pathophysiology of Purtsher Retinopathy
• The condition has been associated with various vasculopathies.
• The most accepted mechanism is leukoembolization that causes
arterial occlusion and infarction of the microvascular bed.
• Other possible sources of emboli include fat emboli, amniotic fluid,
air emboli, and granulocyte aggregation resulting from complement
activation.
Pathophysiology of Purtscher Retinopathy
• Other proposed mechanisms of vascular occlusion include angiospasm
resulting from an acute rise in venous pressure from compressive chest
injuries or possibly acute head injuries and endothelial cell damage
resulting from acutely increased intraluminal pressure.
• Valsalva Retinopathy Pathophysiology:
1. a sudden increase in intrathoracic pressure decreases venous return to the right
side of the heart.
2. diminished cardiac filling lowers the mean arterial pressure, slowing the pulse,
leading to reflex tachycardia and peripheral vasoconstriction.
3. release of the strain causes a prompt reduction in the intrathoracic pressure,
further lowering the blood pressure and simultaneously increasing the cardiac
pressure.
4. an abrupt increase in blood pressure occurs as venous blood surges back to the
heart, inducing reflex bradycardia.
Related Conditions
Related Conditions and Diseases
• Multifocal Chororidopathy Syndromes ;
• Retinal Artery Occlusion;
• Neuroophthalmic manifestations of
vascular eye diseases;
• Hemoglobinopathy Retinopathy
• Eales Disease
• Hiv Retinopathy
• Drug Induced
• Hypertension…
6-6-2019
OD aspetto retinico normale, le vene sembrano un poco congeste.
OS Il sangue continua a riassorbirsi. Nasalmente si apprezza ischemia,
l’aspetto e’ quello di una occlusione venosa di branca. Aspetto a Frosted
Branch Arteritis.
Tp steroidea locale sospesa.
29-6-2019
OS l’emorragia maculare si é completamente riassorbita, il visus
e’risalito a 10/10. Nasalmente si apprezza ischemia.
11-08-2019
Va tutto bene, i sintomi sono completamente rientrati, il visus e’ 10/10.
Al fondo l’ OD e’ normale con leggera congestione venosa.
In OS il polo posteriore e’ praticamente normale, al livello della papilla
un piccolo tuft emorragico e vasi fantasma. Nasalmente si apprezzano
emorragie preretiniche.
I vasi nasalmente presentano come delle calcificazioni biancastre al loro
interno tipo: Kyrieleis Plaques
14-08-2019
Kyrieleis Plaques
Kyrieleis plaques are segmental
periarteriolar inflammatory plaques that
occur in various diseases such as toxoplasma
retinochoroiditis, cytomegalovirus retinitis,
and Susac syndrome
Although first described as of part of a
Tubercolosis related retinitis by Dr Werner
Kyrieleis, calcific plaques on the walls of
blood vessels, have become associated with
toxoplasmosis retinitis.
Labo in our patients shows however IgG + for
Toxo but not IgM
DD SLE, PAN, Lues, HSV, VZV, IRVAN, Churg
Strauss syndr, Sarcoidose, relapsing
polychrondritis, Wegener, Crohn, Frosted
branch angiitis
30-08-2019
Continuiamo a pensare a una Toxo, l’unica lesione che ce lo fa supporre
e’una area depigmentata sotto la papilla correlata tra l’altro a un difetto
superiore del CV.
Pensiamo di fare un puntura in CA per PCR toxo e Herpes ma ci viene
sconsigliata dai colleghi piu’ esperti dell’universita’ di Leiden.
9-9-2019
20-09-2019
Il paziente non ha piu’ sintomi, e’ contento ma non abbiamo una
diagnosi.
IL 6 Novembre e’ programmato per un argon laser della zona ischemica
paranasale.
L’ipotesi piu’ probabile e’ una Periflebite su base infiammatoria o
vascolare (es Eales Disease in assenza di TB, Toxo, Herpes, Occlusione
venosa) oppure danno microvascolare da rialzo acuto di pressione
dovuto al sollevamento pesi, tipo Retinopatia di Purtscher, complicato
da una Maculopatia Valsalva.
3-10-2019
O piu’ probabilmente …..non ci abbiamo capito niente!
Grazie per l’attenzione!!

More Related Content

What's hot

Primary CNS Vasculitis - diagnostic and therapeutic challenges
Primary CNS Vasculitis - diagnostic and therapeutic challengesPrimary CNS Vasculitis - diagnostic and therapeutic challenges
Primary CNS Vasculitis - diagnostic and therapeutic challenges
Diana Girnita
 
Hyperviscosity syndrome CPC
 Hyperviscosity syndrome CPC Hyperviscosity syndrome CPC
Hyperviscosity syndrome CPC
Naseer Nazeer
 
Presentation1 pseudotumor BY DR AMIT LAMBA
Presentation1 pseudotumor BY DR AMIT LAMBAPresentation1 pseudotumor BY DR AMIT LAMBA
Presentation1 pseudotumor BY DR AMIT LAMBA
Drgeeta Choudhary
 
Neurology mc qs
Neurology mc qsNeurology mc qs
Neurology mc qsess_online
 
neurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitisneurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitis
Neurology resident slides
 
Central nervous system vasculitis
Central nervous system vasculitisCentral nervous system vasculitis
Central nervous system vasculitisMohammad Baghbanian
 
Idiopathic Intracranial Hypertension
Idiopathic Intracranial HypertensionIdiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
personalp
 
Cns vasculitis
Cns vasculitisCns vasculitis
Cns vasculitis
NeurologyKota
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathyChandan N
 
Nephrotic&amp;nephritic syn csbrp
Nephrotic&amp;nephritic syn csbrpNephrotic&amp;nephritic syn csbrp
Nephrotic&amp;nephritic syn csbrp
Prasad CSBR
 
Idiopathic intracranial hypertension
Idiopathic intracranial hypertensionIdiopathic intracranial hypertension
Idiopathic intracranial hypertension
Irfaan Shah
 
Uremic Encephalopathy in End Stage Renal Disease A Case Report
Uremic Encephalopathy in End Stage Renal Disease A Case ReportUremic Encephalopathy in End Stage Renal Disease A Case Report
Uremic Encephalopathy in End Stage Renal Disease A Case Report
ijtsrd
 
pseudotumer cerebri
pseudotumer cerebripseudotumer cerebri
pseudotumer cerebri
Ayub Teaching Hospital
 
Primary CNS vasculitis
Primary CNS vasculitisPrimary CNS vasculitis
Primary CNS vasculitis
Yasser Alzainy
 
Genetic stroke syndrome
Genetic stroke syndromeGenetic stroke syndrome
Genetic stroke syndrome
Sarath Menon
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
Haifa Alshwikh
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failureess_online
 
CNS vasculitis
CNS vasculitis CNS vasculitis
CNS vasculitis pkhohl
 
HSP presentation
HSP presentationHSP presentation
HSP presentation
Jafar Assaggaf
 
Antiphospholipid syndrome
Antiphospholipid syndromeAntiphospholipid syndrome
Antiphospholipid syndrome
Anna Rudaja
 

What's hot (20)

Primary CNS Vasculitis - diagnostic and therapeutic challenges
Primary CNS Vasculitis - diagnostic and therapeutic challengesPrimary CNS Vasculitis - diagnostic and therapeutic challenges
Primary CNS Vasculitis - diagnostic and therapeutic challenges
 
Hyperviscosity syndrome CPC
 Hyperviscosity syndrome CPC Hyperviscosity syndrome CPC
Hyperviscosity syndrome CPC
 
Presentation1 pseudotumor BY DR AMIT LAMBA
Presentation1 pseudotumor BY DR AMIT LAMBAPresentation1 pseudotumor BY DR AMIT LAMBA
Presentation1 pseudotumor BY DR AMIT LAMBA
 
Neurology mc qs
Neurology mc qsNeurology mc qs
Neurology mc qs
 
neurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitisneurologic presentations of systemic vasculitis
neurologic presentations of systemic vasculitis
 
Central nervous system vasculitis
Central nervous system vasculitisCentral nervous system vasculitis
Central nervous system vasculitis
 
Idiopathic Intracranial Hypertension
Idiopathic Intracranial HypertensionIdiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
 
Cns vasculitis
Cns vasculitisCns vasculitis
Cns vasculitis
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 
Nephrotic&amp;nephritic syn csbrp
Nephrotic&amp;nephritic syn csbrpNephrotic&amp;nephritic syn csbrp
Nephrotic&amp;nephritic syn csbrp
 
Idiopathic intracranial hypertension
Idiopathic intracranial hypertensionIdiopathic intracranial hypertension
Idiopathic intracranial hypertension
 
Uremic Encephalopathy in End Stage Renal Disease A Case Report
Uremic Encephalopathy in End Stage Renal Disease A Case ReportUremic Encephalopathy in End Stage Renal Disease A Case Report
Uremic Encephalopathy in End Stage Renal Disease A Case Report
 
pseudotumer cerebri
pseudotumer cerebripseudotumer cerebri
pseudotumer cerebri
 
Primary CNS vasculitis
Primary CNS vasculitisPrimary CNS vasculitis
Primary CNS vasculitis
 
Genetic stroke syndrome
Genetic stroke syndromeGenetic stroke syndrome
Genetic stroke syndrome
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
CNS vasculitis
CNS vasculitis CNS vasculitis
CNS vasculitis
 
HSP presentation
HSP presentationHSP presentation
HSP presentation
 
Antiphospholipid syndrome
Antiphospholipid syndromeAntiphospholipid syndrome
Antiphospholipid syndrome
 

Similar to OftaForce 2019: #OFTASNIPER MISSION 1 - G. Bamonte

APS.pptx
APS.pptxAPS.pptx
APS.pptx
Marwa Khalifa
 
Approach to sle
Approach to sleApproach to sle
Adult polycystic kidney disease
Adult polycystic kidney disease Adult polycystic kidney disease
Adult polycystic kidney disease
konderu prathyusha
 
Idiopathic intracranial hypertension
Idiopathic intracranial hypertensionIdiopathic intracranial hypertension
Idiopathic intracranial hypertension
Othman Al-Abbadi
 
Antiphospholipid Syndrome
Antiphospholipid SyndromeAntiphospholipid Syndrome
Antiphospholipid Syndrome
Waleed El-Refaey
 
Macrophage activation
Macrophage activation Macrophage activation
Macrophage activation
Maduka Sanjeewa
 
Git Case Budd Chiari3.
Git Case Budd Chiari3.Git Case Budd Chiari3.
Git Case Budd Chiari3.
Shaikhani.
 
Dr_Chandana eafo presentation 2016
Dr_Chandana eafo presentation 2016Dr_Chandana eafo presentation 2016
Dr_Chandana eafo presentation 2016
EAFO2014
 
FORMATO CASO CLÍNICO U2 M4 T1.docx
FORMATO CASO CLÍNICO U2 M4 T1.docxFORMATO CASO CLÍNICO U2 M4 T1.docx
FORMATO CASO CLÍNICO U2 M4 T1.docx
LissetnoeliaCaruajul
 
SLE Case Presentation
 SLE Case Presentation SLE Case Presentation
SLE Case Presentation
Vishwa Jayasinghe
 
Hunting for a diagnosis
Hunting for a diagnosisHunting for a diagnosis
Hunting for a diagnosis
Maduka Sanjeewa
 
approach to a bleeding child with blood disorders.pptx
approach to a bleeding child  with blood disorders.pptxapproach to a bleeding child  with blood disorders.pptx
approach to a bleeding child with blood disorders.pptx
tsholanangmaoka
 
Benign intracranial hypertension by Dr.Syed Alam Zeb
Benign intracranial hypertension by Dr.Syed Alam ZebBenign intracranial hypertension by Dr.Syed Alam Zeb
Benign intracranial hypertension by Dr.Syed Alam Zeb
Syed Alam Zeb
 
Normal pressure hydrocephalus presentation
Normal pressure hydrocephalus presentationNormal pressure hydrocephalus presentation
Normal pressure hydrocephalus presentation
Beshr Nammouz
 
Secondary Hypertension. final.ppt
Secondary Hypertension. final.pptSecondary Hypertension. final.ppt
Secondary Hypertension. final.ppt
AdelSALLAM4
 
Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)
Marwa Besar
 
Leptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPCLeptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPC
Neurology Residency
 
Von hippel lindau disease
Von hippel lindau diseaseVon hippel lindau disease
Von hippel lindau disease
Fahmida Hoque
 
antiphospholipidsyndrome-141014120624-conversion-gate01 (1).pdf
antiphospholipidsyndrome-141014120624-conversion-gate01 (1).pdfantiphospholipidsyndrome-141014120624-conversion-gate01 (1).pdf
antiphospholipidsyndrome-141014120624-conversion-gate01 (1).pdf
SayaliPatil790915
 
Revisiting Pulmonary embolism Guidelines
Revisiting Pulmonary embolism GuidelinesRevisiting Pulmonary embolism Guidelines
Revisiting Pulmonary embolism Guidelines
Emad Qasem
 

Similar to OftaForce 2019: #OFTASNIPER MISSION 1 - G. Bamonte (20)

APS.pptx
APS.pptxAPS.pptx
APS.pptx
 
Approach to sle
Approach to sleApproach to sle
Approach to sle
 
Adult polycystic kidney disease
Adult polycystic kidney disease Adult polycystic kidney disease
Adult polycystic kidney disease
 
Idiopathic intracranial hypertension
Idiopathic intracranial hypertensionIdiopathic intracranial hypertension
Idiopathic intracranial hypertension
 
Antiphospholipid Syndrome
Antiphospholipid SyndromeAntiphospholipid Syndrome
Antiphospholipid Syndrome
 
Macrophage activation
Macrophage activation Macrophage activation
Macrophage activation
 
Git Case Budd Chiari3.
Git Case Budd Chiari3.Git Case Budd Chiari3.
Git Case Budd Chiari3.
 
Dr_Chandana eafo presentation 2016
Dr_Chandana eafo presentation 2016Dr_Chandana eafo presentation 2016
Dr_Chandana eafo presentation 2016
 
FORMATO CASO CLÍNICO U2 M4 T1.docx
FORMATO CASO CLÍNICO U2 M4 T1.docxFORMATO CASO CLÍNICO U2 M4 T1.docx
FORMATO CASO CLÍNICO U2 M4 T1.docx
 
SLE Case Presentation
 SLE Case Presentation SLE Case Presentation
SLE Case Presentation
 
Hunting for a diagnosis
Hunting for a diagnosisHunting for a diagnosis
Hunting for a diagnosis
 
approach to a bleeding child with blood disorders.pptx
approach to a bleeding child  with blood disorders.pptxapproach to a bleeding child  with blood disorders.pptx
approach to a bleeding child with blood disorders.pptx
 
Benign intracranial hypertension by Dr.Syed Alam Zeb
Benign intracranial hypertension by Dr.Syed Alam ZebBenign intracranial hypertension by Dr.Syed Alam Zeb
Benign intracranial hypertension by Dr.Syed Alam Zeb
 
Normal pressure hydrocephalus presentation
Normal pressure hydrocephalus presentationNormal pressure hydrocephalus presentation
Normal pressure hydrocephalus presentation
 
Secondary Hypertension. final.ppt
Secondary Hypertension. final.pptSecondary Hypertension. final.ppt
Secondary Hypertension. final.ppt
 
Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)
 
Leptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPCLeptomeningeal metastases, differential diagnosis. CPC
Leptomeningeal metastases, differential diagnosis. CPC
 
Von hippel lindau disease
Von hippel lindau diseaseVon hippel lindau disease
Von hippel lindau disease
 
antiphospholipidsyndrome-141014120624-conversion-gate01 (1).pdf
antiphospholipidsyndrome-141014120624-conversion-gate01 (1).pdfantiphospholipidsyndrome-141014120624-conversion-gate01 (1).pdf
antiphospholipidsyndrome-141014120624-conversion-gate01 (1).pdf
 
Revisiting Pulmonary embolism Guidelines
Revisiting Pulmonary embolism GuidelinesRevisiting Pulmonary embolism Guidelines
Revisiting Pulmonary embolism Guidelines
 

More from OFTALMOLOGIA CLINICA

OFTATALKS THREE - Cheratoprotesi di Boston Tipo I Laser-Assistita - Dott. Luc...
OFTATALKS THREE - Cheratoprotesi di Boston Tipo I Laser-Assistita - Dott. Luc...OFTATALKS THREE - Cheratoprotesi di Boston Tipo I Laser-Assistita - Dott. Luc...
OFTATALKS THREE - Cheratoprotesi di Boston Tipo I Laser-Assistita - Dott. Luc...
OFTALMOLOGIA CLINICA
 
OFTATALKS TWO: Autologous transplant of RPE and choroid - B. Parolini
OFTATALKS TWO: Autologous transplant of RPE and choroid - B. ParoliniOFTATALKS TWO: Autologous transplant of RPE and choroid - B. Parolini
OFTATALKS TWO: Autologous transplant of RPE and choroid - B. Parolini
OFTALMOLOGIA CLINICA
 
oftaRESTART - Webinar dpi e mascherine
oftaRESTART - Webinar dpi e mascherineoftaRESTART - Webinar dpi e mascherine
oftaRESTART - Webinar dpi e mascherine
OFTALMOLOGIA CLINICA
 
OFTATALKS ONE (Part III) Clinical Cases on CSC - massimo nicolo
OFTATALKS ONE (Part III)   Clinical Cases on CSC - massimo nicoloOFTATALKS ONE (Part III)   Clinical Cases on CSC - massimo nicolo
OFTATALKS ONE (Part III) Clinical Cases on CSC - massimo nicolo
OFTALMOLOGIA CLINICA
 
OFTATALKS ONE (Part II) Clinical Cases on CSC - Massimo Nicolo
OFTATALKS ONE (Part II)   Clinical Cases on CSC - Massimo NicoloOFTATALKS ONE (Part II)   Clinical Cases on CSC - Massimo Nicolo
OFTATALKS ONE (Part II) Clinical Cases on CSC - Massimo Nicolo
OFTALMOLOGIA CLINICA
 
OFTATALKS ONE (Part I) - Clinical cases on CSC - Prof. Massimo Nicolò
OFTATALKS ONE (Part I) - Clinical cases on CSC - Prof. Massimo NicolòOFTATALKS ONE (Part I) - Clinical cases on CSC - Prof. Massimo Nicolò
OFTATALKS ONE (Part I) - Clinical cases on CSC - Prof. Massimo Nicolò
OFTALMOLOGIA CLINICA
 
OftaForce 2019: #OFTASNIPER MISSION 5 - M.A. Blasi
OftaForce 2019: #OFTASNIPER MISSION 5 - M.A. BlasiOftaForce 2019: #OFTASNIPER MISSION 5 - M.A. Blasi
OftaForce 2019: #OFTASNIPER MISSION 5 - M.A. Blasi
OFTALMOLOGIA CLINICA
 
#OFTALMOLOGIACLINICA - #OFTAFORCE II EDITION
#OFTALMOLOGIACLINICA - #OFTAFORCE II EDITION#OFTALMOLOGIACLINICA - #OFTAFORCE II EDITION
#OFTALMOLOGIACLINICA - #OFTAFORCE II EDITION
OFTALMOLOGIA CLINICA
 
OftaForce 2019: #OFTASNIPER MISSION 6 - R. Zito
OftaForce 2019: #OFTASNIPER MISSION 6 - R. ZitoOftaForce 2019: #OFTASNIPER MISSION 6 - R. Zito
OftaForce 2019: #OFTASNIPER MISSION 6 - R. Zito
OFTALMOLOGIA CLINICA
 
OftaForce 2019: Briefing Mission 6
OftaForce 2019: Briefing Mission 6OftaForce 2019: Briefing Mission 6
OftaForce 2019: Briefing Mission 6
OFTALMOLOGIA CLINICA
 
OftaForce 2019: Briefing Mission 5
OftaForce 2019: Briefing Mission 5OftaForce 2019: Briefing Mission 5
OftaForce 2019: Briefing Mission 5
OFTALMOLOGIA CLINICA
 
OftaForce 2019: #OFTASNIPER MISSION 4 - S. Baiocchi
OftaForce 2019: #OFTASNIPER MISSION 4 - S. BaiocchiOftaForce 2019: #OFTASNIPER MISSION 4 - S. Baiocchi
OftaForce 2019: #OFTASNIPER MISSION 4 - S. Baiocchi
OFTALMOLOGIA CLINICA
 
#OFTAFORCE 2019 - MISSION 4 : BRIEFING
#OFTAFORCE 2019 - MISSION 4 : BRIEFING #OFTAFORCE 2019 - MISSION 4 : BRIEFING
#OFTAFORCE 2019 - MISSION 4 : BRIEFING
OFTALMOLOGIA CLINICA
 
OftaForce 2019: #OFTASNIPER MISSION 3 - M. Rispoli
OftaForce 2019: #OFTASNIPER MISSION 3 - M. RispoliOftaForce 2019: #OFTASNIPER MISSION 3 - M. Rispoli
OftaForce 2019: #OFTASNIPER MISSION 3 - M. Rispoli
OFTALMOLOGIA CLINICA
 
OftaForce 2019: Briefing Mission 3
OftaForce 2019: Briefing Mission 3OftaForce 2019: Briefing Mission 3
OftaForce 2019: Briefing Mission 3
OFTALMOLOGIA CLINICA
 
OftaForce 2019: #OFTASNIPER MISSION 2 - A. Petrone, E. Melchionda
OftaForce 2019: #OFTASNIPER MISSION 2 - A. Petrone, E. Melchionda OftaForce 2019: #OFTASNIPER MISSION 2 - A. Petrone, E. Melchionda
OftaForce 2019: #OFTASNIPER MISSION 2 - A. Petrone, E. Melchionda
OFTALMOLOGIA CLINICA
 
OftaForce 2019: Briefing Mission 2
OftaForce 2019: Briefing Mission 2OftaForce 2019: Briefing Mission 2
OftaForce 2019: Briefing Mission 2
OFTALMOLOGIA CLINICA
 
OftaForce 2019: Briefing Mission 1
OftaForce 2019: Briefing Mission 1OftaForce 2019: Briefing Mission 1
OftaForce 2019: Briefing Mission 1
OFTALMOLOGIA CLINICA
 
Manifesto Programmatico di #OftalmologiaClinica
Manifesto Programmatico di #OftalmologiaClinicaManifesto Programmatico di #OftalmologiaClinica
Manifesto Programmatico di #OftalmologiaClinica
OFTALMOLOGIA CLINICA
 
Fanton: #Oculisti 2.0 digital & social skills
Fanton: #Oculisti 2.0 digital & social skillsFanton: #Oculisti 2.0 digital & social skills
Fanton: #Oculisti 2.0 digital & social skills
OFTALMOLOGIA CLINICA
 

More from OFTALMOLOGIA CLINICA (20)

OFTATALKS THREE - Cheratoprotesi di Boston Tipo I Laser-Assistita - Dott. Luc...
OFTATALKS THREE - Cheratoprotesi di Boston Tipo I Laser-Assistita - Dott. Luc...OFTATALKS THREE - Cheratoprotesi di Boston Tipo I Laser-Assistita - Dott. Luc...
OFTATALKS THREE - Cheratoprotesi di Boston Tipo I Laser-Assistita - Dott. Luc...
 
OFTATALKS TWO: Autologous transplant of RPE and choroid - B. Parolini
OFTATALKS TWO: Autologous transplant of RPE and choroid - B. ParoliniOFTATALKS TWO: Autologous transplant of RPE and choroid - B. Parolini
OFTATALKS TWO: Autologous transplant of RPE and choroid - B. Parolini
 
oftaRESTART - Webinar dpi e mascherine
oftaRESTART - Webinar dpi e mascherineoftaRESTART - Webinar dpi e mascherine
oftaRESTART - Webinar dpi e mascherine
 
OFTATALKS ONE (Part III) Clinical Cases on CSC - massimo nicolo
OFTATALKS ONE (Part III)   Clinical Cases on CSC - massimo nicoloOFTATALKS ONE (Part III)   Clinical Cases on CSC - massimo nicolo
OFTATALKS ONE (Part III) Clinical Cases on CSC - massimo nicolo
 
OFTATALKS ONE (Part II) Clinical Cases on CSC - Massimo Nicolo
OFTATALKS ONE (Part II)   Clinical Cases on CSC - Massimo NicoloOFTATALKS ONE (Part II)   Clinical Cases on CSC - Massimo Nicolo
OFTATALKS ONE (Part II) Clinical Cases on CSC - Massimo Nicolo
 
OFTATALKS ONE (Part I) - Clinical cases on CSC - Prof. Massimo Nicolò
OFTATALKS ONE (Part I) - Clinical cases on CSC - Prof. Massimo NicolòOFTATALKS ONE (Part I) - Clinical cases on CSC - Prof. Massimo Nicolò
OFTATALKS ONE (Part I) - Clinical cases on CSC - Prof. Massimo Nicolò
 
OftaForce 2019: #OFTASNIPER MISSION 5 - M.A. Blasi
OftaForce 2019: #OFTASNIPER MISSION 5 - M.A. BlasiOftaForce 2019: #OFTASNIPER MISSION 5 - M.A. Blasi
OftaForce 2019: #OFTASNIPER MISSION 5 - M.A. Blasi
 
#OFTALMOLOGIACLINICA - #OFTAFORCE II EDITION
#OFTALMOLOGIACLINICA - #OFTAFORCE II EDITION#OFTALMOLOGIACLINICA - #OFTAFORCE II EDITION
#OFTALMOLOGIACLINICA - #OFTAFORCE II EDITION
 
OftaForce 2019: #OFTASNIPER MISSION 6 - R. Zito
OftaForce 2019: #OFTASNIPER MISSION 6 - R. ZitoOftaForce 2019: #OFTASNIPER MISSION 6 - R. Zito
OftaForce 2019: #OFTASNIPER MISSION 6 - R. Zito
 
OftaForce 2019: Briefing Mission 6
OftaForce 2019: Briefing Mission 6OftaForce 2019: Briefing Mission 6
OftaForce 2019: Briefing Mission 6
 
OftaForce 2019: Briefing Mission 5
OftaForce 2019: Briefing Mission 5OftaForce 2019: Briefing Mission 5
OftaForce 2019: Briefing Mission 5
 
OftaForce 2019: #OFTASNIPER MISSION 4 - S. Baiocchi
OftaForce 2019: #OFTASNIPER MISSION 4 - S. BaiocchiOftaForce 2019: #OFTASNIPER MISSION 4 - S. Baiocchi
OftaForce 2019: #OFTASNIPER MISSION 4 - S. Baiocchi
 
#OFTAFORCE 2019 - MISSION 4 : BRIEFING
#OFTAFORCE 2019 - MISSION 4 : BRIEFING #OFTAFORCE 2019 - MISSION 4 : BRIEFING
#OFTAFORCE 2019 - MISSION 4 : BRIEFING
 
OftaForce 2019: #OFTASNIPER MISSION 3 - M. Rispoli
OftaForce 2019: #OFTASNIPER MISSION 3 - M. RispoliOftaForce 2019: #OFTASNIPER MISSION 3 - M. Rispoli
OftaForce 2019: #OFTASNIPER MISSION 3 - M. Rispoli
 
OftaForce 2019: Briefing Mission 3
OftaForce 2019: Briefing Mission 3OftaForce 2019: Briefing Mission 3
OftaForce 2019: Briefing Mission 3
 
OftaForce 2019: #OFTASNIPER MISSION 2 - A. Petrone, E. Melchionda
OftaForce 2019: #OFTASNIPER MISSION 2 - A. Petrone, E. Melchionda OftaForce 2019: #OFTASNIPER MISSION 2 - A. Petrone, E. Melchionda
OftaForce 2019: #OFTASNIPER MISSION 2 - A. Petrone, E. Melchionda
 
OftaForce 2019: Briefing Mission 2
OftaForce 2019: Briefing Mission 2OftaForce 2019: Briefing Mission 2
OftaForce 2019: Briefing Mission 2
 
OftaForce 2019: Briefing Mission 1
OftaForce 2019: Briefing Mission 1OftaForce 2019: Briefing Mission 1
OftaForce 2019: Briefing Mission 1
 
Manifesto Programmatico di #OftalmologiaClinica
Manifesto Programmatico di #OftalmologiaClinicaManifesto Programmatico di #OftalmologiaClinica
Manifesto Programmatico di #OftalmologiaClinica
 
Fanton: #Oculisti 2.0 digital & social skills
Fanton: #Oculisti 2.0 digital & social skillsFanton: #Oculisti 2.0 digital & social skills
Fanton: #Oculisti 2.0 digital & social skills
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 

OftaForce 2019: #OFTASNIPER MISSION 1 - G. Bamonte

  • 1. Popeye Retinopathy Dr Giulio Bamonte- Dr.ssa Rossella Melchionda
  • 2. 13-5-2019 Paziente Ispanico di 26 anni maschio, si presenta in PS con calo del visus da un giorno in OS, prima intermittente con flash e poi dalla mattina permanente. L’OD e’ normale. Visus OD 10/10 nat Visus OS 1/50 nmcl, tono 11mmHg OO. Anamnesi generale, oculare e familiare negativa per patologie degne di nota. Va tutti i giorni in Palestra. DD: Valsalva Retinopathy, viene inviato al Chirurgo VR. Si esegue Retinografia e OCT.
  • 4. Valsalva Retinopathy • Particular form of retinopathy, pre-retinal and hemorrhagic in nature, secondary to a sudden increase in intrathoracic pressure. • It was used to describe retinal hemorrhages in association with heavy lifting, coughing, straining at stool, or vomiting. • Valsalva retinopathy classically manifests as preretinal hemorrhage secondary to rupturing of superficial retinal vessels caused by physical exertion. • The mechanism of a Valsalva maneuver is characterized by a sudden rise in intrathoracic or intraabdominal pressure against a closed glottis, which leads to a rapid rise of intravenous pressure within the eye, causing retinal capillaries to spontaneously rupture.
  • 5. DD of Valsalva Retinopathy Anemic Retinopathy Diabetic Retinopathy Hemorrhagic Posterior Vitreous Detachment Hypertensive Retinopathy Ocular Parasitic Infection Purtscher Retinopathy and Purtscher-like Retinopathy Retinal Macroaneurysm Retinal Vein Occlusion (RVO) Sickle Cell Retinopathy Terson Syndrome
  • 6. 14-5-2019 Alla visita VR oltre quanto visibile in Retinografia si apprezza nei quadranti superiori un aspetto vascolare ristretto, con vasi a salsicciotto. Il segmento anteriore e’ in quiete. Si invia per FAG, visita con esperto Uveiti e consulto internistico. Si esegue FAG.
  • 8. 15-5-2019 Il paziente avverte un leggero discomfort su OS. Situazione oculare invariata. Si consiglia solo riposo. L’esperto di uveiti pone la seguente DD: problema vascolare tipo papilloflebite (Ipertensione, dislipidemia, coagulopatie), problema infiammatorio (meno probabile, Sarcoidosi, Hiv, TBC, Sifilide, MS, Bechet, Chron, PAN).
  • 9. Papillophlebitis • Papillophlebitis is a condition in which the clinical features of central retinal vein occlusion (CRVO) are present but there is no history of vascular disease. • Papillophlebitis is characterized by painless unilateral disc edema and hyperemia, retinal venous engorgement, and a variable extent of intraretinal hemorrhage and macular edema in otherwise healthy adults younger than 50 years. • Papillophlebitis is often associated with systemic vascular disease (eg, arterial hypertension, diabetes) or hematologic disorders. • Corticosteroids, both systemic and periocular, are the mainstay of treatment and are often coupled with anticoagulants such as heparin and/or aspirin to reduce inflammation and treat any underlying coagulopathies
  • 10. Papillophlebitis Q: When and for whom is thrombophilia testing appropriate? A: Because papillophlebitis can be the first sign of an underlying connective tissue disorder (eg, lupus, rheumatoid arthritis), young women may benefit from a hematologic rheumatologic referral. Screening for hypercoagulable status may include the following: • Antiphospholipid antibodies and hyperhomocysteinemia; • Factor V Leiden and prothrombin G20210A mutations; and • Additional thrombotic risk factors such as pregnancy.
  • 11. 20-5-2019 Al controllo si apprezzano 1+ cell in CA + depositi edoteliali. Il vitreo appare limpido. Per il resto invariato. Si instaura tp locale con Prednisolone collirio 6 al di e unguento prima di dormire + cyclolux 2 al di. 22-5-2019 1+ cell in CA e depositi endoteliali, cellule in CV (globuli rossi, spill over?). Visus OS 2/10 con miglioramento dell’emorragia, che sta liberando il centro della macula. I vasi sembrano obliterati sia nasalmente che temporalmente, possibile vasculite. Le arteriole sono ristrette, sembra aspetto a vasculite venosa.
  • 12. Visita Internistica: Pz Ecuadoregno. Ultimo viaggio un anno prima. Un anno prima negativo STD. No contatti TB. Anamnesi prossima negativa. Anamnesi remota positiva per polmonite a 5 mesi di vita. Nega assuzione di droghe e alcol (sociale). In un relazione fissa da 6 anni. Esame fisico e di Laboratorio negativo
  • 13. Visita internistica 20-5-2019 • Controles: RR 130/93, pols 62/min, Lengte: 162cm, gewicht 72kg (met kleding), BMI 27, H/H: geen lymfadenopathie in de hals of supraclaviculair. Inspectie keel: geen roodheid, geen zwelling. Cor: S1S2, geen souffle Pulm: beiderzijds VAG zonder bijgeluiden Abd: soepel, NP, WT, geen drukpijn, geen hepatosplemomegalie Extr: soepele kuiten, geen oedemen Geen huidafwijkingen, behoudens enkele puistjes op de thorax. Geen afwijkingen aan de nagels. • Laboratorium 16-06 Ureum 4.1, Kreatinine 82, natrium 142, kalium 4.3, ASAT 26, ALAT 30, LD 161, Bilirubine 9, Alk Fos 81, Hb 10.0, Leukocyten 7.5, Trombocyten 238, Bezinking 2, CRP <1, Ferritine 131, Vit B12 323, Foliumzuur 11.4 • Conclusie: Retinabloeding links met atypisch beeld bij oogheelkundig onderzoek mogelijk passend bij vasculitis dan wel veneus occlusie beeld DD - Cardiovasculair (HT, dyslipidemie) - Trombus bij hypercoagulabiliteit (factor V Leiden, homocysteinemie, antifosfolipiden) - Papillophlebitis t.g.v. inflammatie, echter inflammatieparamters laag (vasculitis ihkv M. Behcet, Crohn, PAN, sarcoïdose, MS, SLE; infectieus ihkv HIV, CMV, Syfilis, toxoplasmose, TB (Eales disease), virale hepatitis) • Beleid: Aanvullend lab: lipidenspectrum, HbA1c, nuchter glucose - USED + totaal eiwit, kreatinine, microalbumine - Controle 1-2 weken met Dynamap vooraf - Te bespreken: ANA/ANCA, factor V Leiden, homocysteine, antifosfolipiden - PM: TB, HIV, CMV, toxoplasmose screening • 22-5-2019 Lijkt een veneus probleem (DD trombotisch danwel inflammatoir), overige is er secundair aan. - Vandaag nog prikken: antifosfolipidensyndroom (Lupus anticoagulans, anti cardiolipine, beta-2 glycoproteine), complement (C1q, C3, C4), ANA screening, HIV, Lues serologie - X-thorax bij nog sarcoïdose in de DD - Controle a.s. maandag reeds gepland --> dan 24-uurs bloeddrukmeting regelen ter uitsluiting nachtelijke hypertensie - Geen antistolling, geen reden voor prikken stollingsfactoren
  • 14. Visita internistica 27-5-2019 Dynamap: RR 115/65 mmHg Lab: Ur 4.1 Kreat 88 Leverchemie nl Hb 10 MCV 87 T 238 L 7.5 BSE 2 INR 1.0 APTT 26 Hba1c 35 Lipiden: Cholesterol 4.6 TG 1.0 LDL 3.6 APS: beta 2 glycoproteine, cardiolipine IgM/IgG negatief. Lupus anticoagulans volgt Complement: volgt ANA screening: < 0.5 Sarcoidose: ACE, S-IL2R volgt Used: leuko's, eiwit, ery's negatief. MMB HIV: negatief T.Pallidum negatief. TB quantiferon negatief. X-Thorax: Normale thorax. Geen aanwijzing voor sarcoïdose. Conclusie: - Cardiovasculair DD Hypertensie. Geen dislypidemie (LDL 3.6) > 24u BD meting volgt DD Trombus bij hypercoagulabiliteit ikv factor V Leiden, homocysteinemie, antifosfolipiden >cardiolipine, betaglycoproteine neg, lupus anticoagulans volgt - Retinale vasculitis, echter BSE laag (2) DD auto-immuun mgk ihkv M. Behcet, Crohn, PAN, sarcoïdose, MS, SLE, GCA > ANA negatief > s-IL2R/ACE volgt > complement volgt DD infectieus, mgk ihkv CMV, Toxoplasmose, HSV/VZV, CMV). > HIV/Lues/ TB serologie negatief Beleid - 24u bloeddrukmeting ter uitsluiting nachtelijke hypertensie PM volgende keer dieetadvies (LDL 3.6) PM nog FVL en homocysteine bepalen? --> iom Soonwala, niet nodig, gezien geen behandelconsequenties (geen zin om antistolling te starten)
  • 15. 27-5-2019 Visita Oculistica con FAG: nasalmente si apprezza ischemia, ma l’area e’ ancora coperta dal sangue. Aspetto a Frosted Branch Arteritis (che pero’prende sia vene che arterie)? In CA le cellule sono diminuite. Tp steroidea locale a scalare.
  • 17. Frosted Branch Angiitis • Usually bilateral • Specific Syndrome (primary form): rare, children or young adults • Common immune pathway in responde to multiple infective agents: CMV retinitis. • Oher conditions suchs glomerulonefritis and CRVO
  • 18. Frosted Branch Angiitis Visual Acuity usually very poor Florid translucent retinal perivascular sheating of both arteriooles and venules Anterior uveitis, vitritis and retinal oedema Papillitis, hard exudates, retinal hemorrhages and venous occulsion TP is with steroid.
  • 19. 28-5-2019 Consulto con collega dell’Universita’ di Leiden: sospetta Valsalva in un caso di Retinopatia Purtscher che tuttavia da’ una problematica di solito a livello del polo posteriore, qui il problema e’ nasale (papillo flebite/crvo).
  • 20. Purtscher Retinopathy • Purtscher retinopathy is a hemorrhagic and vasoocclusive vasculopathy, which, was first described as a syndrome of sudden blindness associated with severe head trauma. These patients had findings of multiple white retinal patches and retinal hemorrhages that were associated with severe vision loss. • Purtscher (and Purtscher like) retinopathy has been associated with traumatic injury, primarily blunt thoracic trauma and head trauma, and numerous nontraumatic diseases.
  • 21. DD of Purtscher Retinopathy • Acute Pancreatitis; • fat embolization; • amniotic fluid embolization; • preeclampsia; • hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome; • and vasculitic diseases, such as lupus. Patients with known vasculitic disease (eg, systemic lupus erythematosus, scleroderma, dermatomyositis) are at risk for developing a Purtscher-like retinopathy with microvascular occlusion
  • 22. Pathophysiology of Purtsher Retinopathy • These lesions are known as Purtscher flecken (larger infarcts of the retinal capillary bed) and cotton-wool spots (small retinal microinfarcts at the level of the nerve fiber layer). • Fluorescein leakage in Purtscher retinopathy suggests that an acute endothelial cell injury is caused by trauma, possibly predisposing the retinal vessels to occlusion
  • 23. Pathophysiology of Purtsher Retinopathy • The condition has been associated with various vasculopathies. • The most accepted mechanism is leukoembolization that causes arterial occlusion and infarction of the microvascular bed. • Other possible sources of emboli include fat emboli, amniotic fluid, air emboli, and granulocyte aggregation resulting from complement activation.
  • 24. Pathophysiology of Purtscher Retinopathy • Other proposed mechanisms of vascular occlusion include angiospasm resulting from an acute rise in venous pressure from compressive chest injuries or possibly acute head injuries and endothelial cell damage resulting from acutely increased intraluminal pressure. • Valsalva Retinopathy Pathophysiology: 1. a sudden increase in intrathoracic pressure decreases venous return to the right side of the heart. 2. diminished cardiac filling lowers the mean arterial pressure, slowing the pulse, leading to reflex tachycardia and peripheral vasoconstriction. 3. release of the strain causes a prompt reduction in the intrathoracic pressure, further lowering the blood pressure and simultaneously increasing the cardiac pressure. 4. an abrupt increase in blood pressure occurs as venous blood surges back to the heart, inducing reflex bradycardia.
  • 25. Related Conditions Related Conditions and Diseases • Multifocal Chororidopathy Syndromes ; • Retinal Artery Occlusion; • Neuroophthalmic manifestations of vascular eye diseases; • Hemoglobinopathy Retinopathy • Eales Disease • Hiv Retinopathy • Drug Induced • Hypertension…
  • 26. 6-6-2019 OD aspetto retinico normale, le vene sembrano un poco congeste. OS Il sangue continua a riassorbirsi. Nasalmente si apprezza ischemia, l’aspetto e’ quello di una occlusione venosa di branca. Aspetto a Frosted Branch Arteritis. Tp steroidea locale sospesa. 29-6-2019 OS l’emorragia maculare si é completamente riassorbita, il visus e’risalito a 10/10. Nasalmente si apprezza ischemia.
  • 27. 11-08-2019 Va tutto bene, i sintomi sono completamente rientrati, il visus e’ 10/10. Al fondo l’ OD e’ normale con leggera congestione venosa. In OS il polo posteriore e’ praticamente normale, al livello della papilla un piccolo tuft emorragico e vasi fantasma. Nasalmente si apprezzano emorragie preretiniche. I vasi nasalmente presentano come delle calcificazioni biancastre al loro interno tipo: Kyrieleis Plaques
  • 29. Kyrieleis Plaques Kyrieleis plaques are segmental periarteriolar inflammatory plaques that occur in various diseases such as toxoplasma retinochoroiditis, cytomegalovirus retinitis, and Susac syndrome Although first described as of part of a Tubercolosis related retinitis by Dr Werner Kyrieleis, calcific plaques on the walls of blood vessels, have become associated with toxoplasmosis retinitis. Labo in our patients shows however IgG + for Toxo but not IgM DD SLE, PAN, Lues, HSV, VZV, IRVAN, Churg Strauss syndr, Sarcoidose, relapsing polychrondritis, Wegener, Crohn, Frosted branch angiitis
  • 30. 30-08-2019 Continuiamo a pensare a una Toxo, l’unica lesione che ce lo fa supporre e’una area depigmentata sotto la papilla correlata tra l’altro a un difetto superiore del CV. Pensiamo di fare un puntura in CA per PCR toxo e Herpes ma ci viene sconsigliata dai colleghi piu’ esperti dell’universita’ di Leiden.
  • 31.
  • 33. 20-09-2019 Il paziente non ha piu’ sintomi, e’ contento ma non abbiamo una diagnosi. IL 6 Novembre e’ programmato per un argon laser della zona ischemica paranasale. L’ipotesi piu’ probabile e’ una Periflebite su base infiammatoria o vascolare (es Eales Disease in assenza di TB, Toxo, Herpes, Occlusione venosa) oppure danno microvascolare da rialzo acuto di pressione dovuto al sollevamento pesi, tipo Retinopatia di Purtscher, complicato da una Maculopatia Valsalva.
  • 34. 3-10-2019 O piu’ probabilmente …..non ci abbiamo capito niente! Grazie per l’attenzione!!